Home PharmaCyte Biotech Appoints American Stock Transfer as New Stock Transfer Agent
 

Keywords :   


PharmaCyte Biotech Appoints American Stock Transfer as New Stock Transfer Agent

2015-07-10 00:21:48| Biotech - Topix.net

PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , announced today that, effective July 10, 2015, American Stock Transfer & Trust Company will replace Signature Stock Transfer as its stock transfer and dividend disbursing agent. The Chief Executive Officer of PharmaCyte Biotech, Kenneth L. Waggoner, commented on PharmaCyte Biotech's new stock transfer agent, "We are extremely pleased to announce that we have appointed AST to be our new stock transfer agent.

Tags: american stock agent transfer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »